This Article Full Text Full Text (PDF) All Versions of this Article: 29/3/279    most recent ATVBAHA.108.179796v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, E. S.H. Articles by Menon, V. Search for Related Content PubMed PubMed Citation Articles by Kim, E. S.H. Articles by Menon, V. Pubmed/NCBI databases Medline Plus Health Information Clinical Trials Women's Health Related Collections Go Red For Women Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:279.)
© 2009 American Heart Association, Inc.

Go Red for Women

Status of Women in Cardiovascular Clinical Trials

Esther S.H. Kim; Venu Menon

From the Department of Cardiovascular Medicine of the Cleveland Clinic, Ohio.

Correspondence to Venu Menon, MD, Department of Cardiovascular Medicine, Desk J1-5, 9500 Euclid Avenue, Cleveland, OH 44195. E-mail menonv@ccf.org

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	The Burden of Cardiovascular Disease in Women

 
Cardiovascular disease (CVD) is the most common cause of death in American women and accounts for a full one-third of all deaths.¹ Although the common perception may be that CVD affects mainly men, there is equal prevalence of this disease between the genders by the age of 40, and by the age of 60 more women than men are affected. More women than men have died from CVD causes on a yearly basis since the mid 1980s, and whereas the CVD mortality has steadily declined in men over the past 30 years, it has remained steady in women until very recently when CVD mortality was noted to decrease for both genders.²

See accompanying article on page 277

The impact of cardiovascular disease (CVD) on the health status of American women is gaining more recognition and has become the focus of public education efforts such as the "Go Red for Women" campaign sponsored by the American Heart Association and the "Red Dress" project sponsored by the Department of Health and Human Services, the National Institutes of Health (NIH), and the National Heart Lung and Blood Institute (NHLBI). These programs are, in part, a response to the increasing awareness of cardiovascular disease as a major source of morbidity and mortality in U.S. women.

	Inclusion of Women in Clinical Trials: A Historical Perspective

 
The importance of CVD as a major source of mortality in women was recognized early on by federally funded institutes including the Public Health Service Task Force, which brought attention to concerns about the health information available to women . . . [Full Text of this Article]

Related Article:

Cardiovascular Disease in Women

Nigel Mackman and Susan Smyth
Arterioscler Thromb Vasc Biol 2009 29: 277-278. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				N. Mackman and S. Smyth Cardiovascular Disease in Women Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 277 - 278. [Full Text] [PDF]